1. CMU Intellectual Repository

Browsing by Author Surakit Nathisuwan

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 13 to 18 of 18 < previous 
Issue DateTitleAuthor(s)
1-Jan-2020Prescriber compliance to direct oral anticoagulant labels and impact on outcomes in ThailandPhannita Wattanaruengchai; Surakit Nathisuwan; Wipharak Rattanavipanon; Suvatna Chulavatnatol; Junporn Kongwatcharapong; Phatcharin Mitsuntisuk; Thanaputt Chaiyasothi; Duangkamon Kritsanapipat; Arintaya Phrommintikul; Nathorn Chaiyakunapruk; Khanchit Likittanasombat; Gregory Y.H. Lip
11-Oct-2021Prospective randomised trial examining the impact of an educational intervention versus usual care on anticoagulation therapy control based on an SAMe-TT 2 R 2 score-guided strategy in anticoagulant-naïve Thai patients with atrial fibrillation (TREATS-AF): A study protocolArintaya Phrommintikul; Surakit Nathisuwan; Siriluck Gunaparn; Rungroj Krittayaphong; Wanwarang Wongcharoen; Sukhi Sehmi; Samir Mehta; Neil Winkles; Peter Brocklehurst; Jonathan Mathers; Sue Jowett; Kate Jolly; Deirdre Lane; G. Neil Thomas; Gregory Y.H. Lip
1-Jan-2020Real-World Comparative Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants vs. Warfarin in a Developing CountryPhatcharin Mitsuntisuk; Surakit Nathisuwan; Athirat Junpanichjaroen; Wanwarang Wongcharoen; Arintaya Phrommintikul; Phannita Wattanaruengchai; Wipharak Rattanavipanon; Suvatna Chulavatnatol; Nathorn Chaiyakunapruk; Khanchit Likittanasombat; Gregory Y.H. Lip
1-Jan-2018Relationship of medication adherence and quality of life among heart failure patientsVoratima Silavanich; Surakit Nathisuwan; Arintaya Phrommintikul; Unchalee Permsuwan
1-Apr-2019Roles of pharmacogenomics in non-anthracycline antineoplastic-induced cardiovascular toxicities: A systematic review and meta-analysis of genotypes effectSiew Lian Leong; Nathorn Chaiyakunapruk; Wichittra Tassaneeyakul; Poukwan Arunmanakul; Surakit Nathisuwan; Shaun Wen Huey Lee
1-Sep-2022Using real world evidence to generate cost-effectiveness analysis of fibrinolytic therapy in patients with ST-segment elevation myocardial infarction in ThailandKrittimeth Trerayapiwat; Peerawat Jinatongthai; Prin Vathesatogkit; Piyamitr Sritara; Ninutcha Paengsai; Piyameth Dilokthornsakul; Surakit Nathisuwan; Lan My Le; Nathorn Chaiyakunapruk
Showing results 13 to 18 of 18 < previous